Currently, SITC has more than 2,400 members, representing 22 medical specialties from 42 countries around the world, who are engaged in the research and treatment of cancer.
The goals of SITC are directed towards the rapid dissemination of information in these areas to expedite the safe transfer of both basic and applied research to the clinical setting.
In 2018, SITC grew to more than 2,400 members, representing 22 medical specialties and 42 countries around the world and are engaged in research and treatment of cancer.
It is an open access, online journal created by the Society for the many stakeholders in the tumor immunology and cancer immunotherapy community.
JITC is an outlet and targeted publication platform dedicated to advancing the science of tumor immunology and cancer immunotherapy.